Evaluation of Individual Learning Objectives

Bioterrorism

 

Name:

E-mail address:

To assess the effectiveness of the course material, we ask that you evaluate your achievement of each learning objective on a scale of A to D (A=excellent, B=good, C=fair, D=unsatisfactory). Please indicate your responses next to each learning objective and submit it as part of the course assignment.

 

Chapter 3: The Prospect of Domestic Bioterrorism
  1. Discuss the prospect of domestic terrorism and describe the motivational, technical and organizational factors that may help or hamper the perpetrators.

A B  C   D

Chapter 5: Epidemiology of Bioterrorism
  1. Define indication of intentional release of biologic agent.

A B  C   D

  1. Describe the precautions laboratory personnel should take when collecting or handling clinical specimens.

A B  C   D

  1. Discuss the epidemiology of bioterrorism and differentiate between a natural outbreak an intentional attack.

A B  C   D

  1. List 10 clues that together may constitue proof of intentional use of biological agent.

A B  C   D

Chapter 7: Anthrax
  1. Describe the side effects of taking ciprofloxacin and doxycycline.

A B  C   D

  1. Describe recommendations made by the CDC for worker safety under engineering controls, administrative controls, housekeeping controls, and personal protective equipment.

A B  C   D

  1. Implement anthrax worker safety guidelines issued by the CDC.

A B  C   D

  1. Describe the epidemiology of naturally occurring anthrax.

A B  C   D

10.  Discuss the diagnosis of inhalational anthrax.

A B  C   D

11.  Discuss the therapeutic options of anthrax infection.

A B  C   D

12.  Discuss infection control and decontamination protocols for anthrax.

A B  C   D

13.  Describe the procedure for handling suspicious packages or envelopes.

A B  C   D

14.  Provide medication information to patients about ciprofloxacin, doxycycline, penicillin, and amoxicillin.

A B  C   D

15.  Discuss clinical issues in the prophylaxis, diagnosis, and treatment of anthrax.

A B  C   D

Chapter 8: Smallpox

16.  Describe various phases of the smallpox disease, symptoms, and degree of infectiousness.

A B  C   D

17.  Answer questions about the smallpox disease and the vaccine.

A B  C   D

18.  List the categories of people who should not get vaccine.

A B  C   D

19.  List the steps that one should take after vaccination to minimize the risk of spreading vaccinia.

A B  C   D

Chapter 9: Botulism

20.  Describe three main kinds of botulism and their mode of transmission.

A B  C   D

21.  Answer frequently asked questions about botulism.

A B  C   D

22.  List symptoms of botulism.

A B  C   D

23.  Describe infant botulism, its epidemiology, source of C. botulinum , and prevention and control.

A B  C   D

24.  Describe the clinical syndrome of botulism and provide a diagnosis of the disease.

A B  C   D

25.  Put the use of botulinum toxin as a bioweapon in historical perspective.

A B  C   D

26.  Describe the pathogenesis and clinical manifestations of botulism.

A B  C   D

27.  List typical symptoms and signs of foodborne botulism.

A B  C   D

28.  Identify features of an outbreak that would indicate a bioterrorist attack with botulinum toxin.

A B  C   D

29.  Describe the therapy, prophylaxis and decontamination for botulinum toxin.

A B  C   D

Chapter 10: Plague

30.  Answer frequently asked questions about pneumonic and bubonic plague, their signs and symptoms, and treatment.

A B  C   D

31.  Describe the role fleas play in the spread of plague to humans.

A B  C   D

32.  Explain the epidemiology of plague.

A B  C   D

33.  Describe clinical manifestations of bubonic, septicemic, pneumonic, and pharyngeal plague.

A B  C   D

34.  Discuss signs and symptoms and laboratory confirmation that can establish the diagnosis of plague.

A B  C   D

35.  Describe the treatment for plague.

A B  C   D

36.  Outline the strategies for the prevention of plague.

A B  C   D

Chapter 11: Tularemia

37.  Answer frequently asked questions about tularemia.

A B  C   D

38.  Describe the signs and symptoms of tularemia.

A B  C   D

39.  Identify epidemiological indicators that would suggest a bioterrorism act of inhalational tularemia.

A B  C   D

40.  Describe the pathogenesis and clinical manifestations of F. tularensis.

A B  C   D

41.  Provide a diagnosis of inhalational tularemia following its use as a biological weapon.

A B  C   D

42.  Describe the treatment of tularemia in adults and children.

A B  C   D

43.  Make recommendations for postexposure antibiotic prophylactic treatment in the event of F. tularensis biological attack.

A B  C   D

Chapter 12: Viral Hemorrhagic Fevers

44.  Answer frequently asked questions about the etiology and epidemiology of viral hemorrhagic fevers.

A B  C   D

45.  Describe various ways of preventing and controlling viral hemorrhagic fevers.

A B  C   D

46.  Describe the history and potential of HFVs as biological weapons.

A B  C   D

47.  Describe the clinical manifestations of diseases caused by hemorrhagic fever viruses.

A B  C   D

48.  Provide a diagnosis of viral hemorrhagic fevers and treatment options including drug therapy.

A B  C   D

Chapter 13: Ricin

49.  Answer frequently asked questions about ricin, its signs and symptoms, and its potential for bioterrorism.

A B  C   D

Chapter 14: Nerve Agents

50.  Answer frequently asked questions about nerve agents, GA, GB, GD and VX.

A B  C   D

51.  Describe the signs and symptoms of nerve agents GA, GB, GD and VX, and their effects on health.

A B  C   D

52.  List the things people can do to protect themselves against VX and things they should do if they are exposed to VX.

A B  C   D

53.  Describe the health effects of nerve agents, GA, GB, GD, and VX.

A B  C   D

54.  Describe the prehospital management of victims of nerve agent attack.

A B  C   D

Chapter 15: Blister Agents

55.  Describe the health effects of sulfur mustard on various body systems.

A B  C   D

56.  Describe prehospital management of victims exposed to sulfur mustard.

A B  C   D

57.  List general principles of triage for chemical exposures.

A B  C   D

58.  Describe triage for mustard agent casualties.

A B  C   D

Chapter 16: Foodborne Illness

59.  Describe some of the most common foodborne diseases.

A B  C   D

60.  Identify instances when a doctor should be consulted for a diarrheal illness.

A B  C   D

61.  Describe how outbreaks of foodborne disease are detected and investigated.

A B  C   D

62.  Describe the ways food can become contaminated.

A B  C   D

63.  List foods that are most associated with foodborne illness.

A B  C   D

64.  State five simple precautions one can take to reduce the risk of foodborne diseases.

A B  C   D

65.  Identify persons who are at particularly high risk to contract a foodborne illness.

A B  C   D

Chapter 17: Escherichia coli O157:H7

66.  List various ways Escherichia coli O157:H7 is spread.

A B  C   D

67.  Describe the illness caused by Escherichia coli O157:H7.

A B  C   D

Chapter 18: Salmonellosis

68.  Answer frequently asked questions about salmonellosis, including how people can catch Salmonella, its health consequences and treatment.

A B  C   D

69.  List eight things one can do to prevent salmonellosis.

A B  C   D

Chapter 19: Cholera

70.  List six things a traveler can do to avoid getting cholera.

A B  C   D

Chapter 20: Shigellosis

71.  Answer frequently asked questions about shigellosis.

A B  C   D

72.  List eight tips for preventing the spread of shigellosis.

A B  C   D

Chapter 21: Brucellosis

73.  Answer frequently asked questions about brucellosis, such as how it is transmitted to humans, ways to prevent infection, and its treatment.

A B  C   D

Chapter 22: Typhoid Fever

74.  Answer frequently asked questions about typhoid fever.

A B  C   D

75.  List steps one can take to avoid typhoid fever.

A B  C   D

Chapter 24: Injuries and Mass Trauma Events

76.  Describe symptoms of posttraumatic stress disorder.

A B  C   D

77.  Identify the kind of injuries that occur in mass trauma events.

A B  C   D

78.  List the things health departments should do to prepare for and subsequent to mass trauma events.

A B  C   D

79.  Identify various steps one should plan to escape from home, workplace or hotel.

A B  C   D

80.  Describe 3 types of burns, their symptoms and early treatment.

A B  C   D

81.  List signs and symptoms after a mild traumatic brain injury (MTBI).

A B  C   D

82.  Describe the procedure for personal cleaning and disposal of contaminated clothing.

A B  C   D

83.  Describe the evacuation procedure in the event of a chemical accident or attack.

A B  C   D

84.  Describe how to prepare to shelter in place in case of a chemical accident or attack.

A B  C   D

85.  Allay general public’s concerns about the safety of drinking water.

A B  C   D

86.  Describe emergency room procedures in chemical hazard emergencies.

A B  C   D

Chapter 25: Bioterrorism Readiness Plan: A Template for Healthcare Facilities

87.  Develop and implement a bioterrorism readiness plan appropriate for a particular healthcare facility.

A B  C   D

88.  Identify 6 features that should alert healthcare providers to the possibility of a bioterrorism-related outbreak.

A B  C   D

89.  Describe clinical features of anthrax infection, infection control practices for patient management, and post-exposure management.

A B  C   D

90.  Describe clinical features of botulism infection, infection control practices for patient management and post-exposure management.

A B  C   D

91.  Describe clinical features of pneumonic plague, infection control practices for patient management, and post-exposure management.

A B  C   D